Jinxi Liu

Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program

S. Brunak, X. Pi-Sunyer, R. Goldberg, 2021, BMJ Open Diabetes Research & Care.

Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program trial.

Paige L. Williams, G. Bray, W. Knowler, 2020, International journal of hygiene and environmental health.

Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program

Thomas J. Wang, J. Florez, W. Knowler, 2019, Diabetes.

Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts

Richard D Moore, H. Masur, C. Dieffenbach, 2021, Open forum infectious diseases.